Progress of blastic plasmacytoid dendritic cell neoplasms
10.3760/cma.j.issn.1009-9921.2019.11.016
- VernacularTitle: 母细胞性浆细胞样树突细胞肿瘤的研究进展
- Author:
Xiuping WANG
1
;
Jingyun SHI
2
;
Tao WU
1
;
Hai BAI
1
Author Information
1. Department of Hematology, Lanzhou General Hospital, Lanzhou Command, Lanzhou 730050, China
2. Department of Neonatology, Gansu Provincial Maternity and Child-Care Hospital, Lanzhou 730050, China
- Publication Type:Review
- Keywords:
Hematologic neoplasms;
Blastic plasmacytoid dendritic cell neoplasm;
Molecular targeted therapy;
Hematopoietic stem cell transplantation;
Combined modality therapy
- From:
Journal of Leukemia & Lymphoma
2019;28(11):698-701
- CountryChina
- Language:Chinese
-
Abstract:
Blastic plasmacytoid dendritic cell neoplasm (BPDCN) is a kind of highly malignant tumor in the hematological system, which is characterized with low incidence, diverse clinical manifestations, strong invasiveness and poor prognosis, however, currently there has no standard treatment yet. This paper reviews the recent research progress of BPDCN.
